Cardoxal: Began Phase I trial

Medicure Inc. (CDNX:MPH), Winnipeg, Manitoba Product: Cardoxal Business: Cardiovascular Therapeutic category: Not disclosed Target: Not disclosed Description: Oral small molecule cardioprotectant Ind...